• Mashup Score: 2
    Home | Smokefree - 8 month(s) ago

    Find information, resources, and support to help you get ready to quit tobacco and successfully stop smoking.

    Tweet Tweets with this article
    • Cigarette smoking is the #1 cause of #LungCancer. Quitting smoking at any age can lower your risk. On this #WorldLungCancerDay, find tips on #QuittingSmoking: https://t.co/SeWeUUavDr https://t.co/4IZgTM60C8

  • Mashup Score: 10

    NCI has helped launch the Pragmatica-Lung Study, a phase 3 randomized clinical trial of a two-drug combination to treat patients with advanced non-small cell lung cancer.

    Tweet Tweets with this article
    • NCI has helped launch a randomized clinical trial for people with advanced non-small cell lung cancer (#NSCLC). The Pragmatica-Lung Study could be a model for increasing diversity and enrollment in trials. https://t.co/zPJ9AGMTQU #NationalCancerPlan #WorldLungCancerDay

  • Mashup Score: 0

    CHICAGO — A study that assessed the feasibility of lung cancer screening for certain nonsmokers yielded a higher invasive adenocarcinoma detection rate than the National Lung Screening Trial, which assessed screening for smokers who met key risk criteria.The findings — presented at ASCO Annual Meeting — highlight the need for more emphasis on early detection of lung cancer among

    Tweet Tweets with this article
    • ICYMI: Findings presented at #ASCO2023 showed that the feasibility of lung cancer screening for certain nonsmokers yielded a higher invasive adenocarcinoma detection rate than the National Lung Screening Trial. #WorldLungCancerDay https://t.co/6TFXlhnPiX

  • Mashup Score: 5
    Lung-MAP Clinical Trial - 8 month(s) ago

    The Lung Cancer Master Protocol, or Lung-MAP, is a precision medicine research study for people with advanced non-small cell lung cancer that has continued to grow after treatment. Patients are assigned to different study drug combinations based on the results of genomic profiling of their tumors.

    Tweet Tweets with this article
    • A precision medicine clinical trial is available for people with advanced non-small cell lung cancer that continues to grow after treatment. https://t.co/JD4WKJ9iSf #LungMAP #NSCLC #WorldLungCancerDay @SWOG https://t.co/zjKQLXCcdo